3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Conditions
Whooping Cough
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pneumococcal Infections
1
Neoplasm Metastasis
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Measles
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Hodgkin Disease
1
Hepatitis B
1
HIV Infections
1
Interventions
Cytarabine
19
Cyclophosphamide
18
venetoclax
15
fludarabine phosphate
14
Busulfan
14
Cyclosporine
12
Azacitidine
11
fludarabine
10
Peripheral Blood Stem Cell Transplantation
10
Granulocyte Colony-Stimulating Factor
10
Mycophenolic Acid
9
Filgrastim
9
Melphalan
8
Antilymphocyte Serum
8
Whole-Body Irradiation
7
Palliative Care
7
Idarubicin
6
Blood Specimen Collection
6
Methotrexate
5
Therapeutics
4
Specimen Handling
4
Radiotherapy
4
Methods
4
Early Intervention, Educational
4
Daunorubicin
4
Cord Blood Stem Cell Transplantation
4
thymoglobulin
3
Thiotepa
3
Tacrolimus
3
Psychiatric Rehabilitation
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Leukemia, Myeloid, Acute
×
Tetanus Toxoid
×
Clear all
NCT01611298
2020-04-21
TAR
Baylor College of Medicine
Phase NA
Completed
7 enrolled
8 charts